PMC:7091888 / 30191-30430 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"1174","span":{"begin":198,"end":208},"obj":"Gene"},{"id":"1175","span":{"begin":35,"end":45},"obj":"Species"},{"id":"1176","span":{"begin":136,"end":146},"obj":"Species"}],"attributes":[{"id":"A1174","pred":"tao:has_database_id","subj":"1174","obj":"Gene:59272"},{"id":"A1175","pred":"tao:has_database_id","subj":"1175","obj":"Tax:2697049"},{"id":"A1176","pred":"tao:has_database_id","subj":"1176","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Inhibition of pseudovirus entry by SARS-CoV-2 RBD protein was carried out, as previously described, with some modifications.31 Briefly, SARS-CoV-2 RBD protein at serial dilutions was incubated with hACE2/293T target cells for 1 h at 37 °C."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T243","span":{"begin":50,"end":57},"obj":"Body_part"},{"id":"T244","span":{"begin":151,"end":158},"obj":"Body_part"},{"id":"T245","span":{"begin":216,"end":221},"obj":"Body_part"}],"attributes":[{"id":"A243","pred":"fma_id","subj":"T243","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A244","pred":"fma_id","subj":"T244","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A245","pred":"fma_id","subj":"T245","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Inhibition of pseudovirus entry by SARS-CoV-2 RBD protein was carried out, as previously described, with some modifications.31 Briefly, SARS-CoV-2 RBD protein at serial dilutions was incubated with hACE2/293T target cells for 1 h at 37 °C."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T509","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"T510","span":{"begin":35,"end":39},"obj":"Disease"},{"id":"T511","span":{"begin":136,"end":144},"obj":"Disease"},{"id":"T512","span":{"begin":136,"end":140},"obj":"Disease"}],"attributes":[{"id":"A509","pred":"mondo_id","subj":"T509","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A510","pred":"mondo_id","subj":"T510","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A511","pred":"mondo_id","subj":"T511","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A512","pred":"mondo_id","subj":"T512","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Inhibition of pseudovirus entry by SARS-CoV-2 RBD protein was carried out, as previously described, with some modifications.31 Briefly, SARS-CoV-2 RBD protein at serial dilutions was incubated with hACE2/293T target cells for 1 h at 37 °C."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T510","span":{"begin":204,"end":208},"obj":"http://purl.obolibrary.org/obo/CLO_0050894"},{"id":"T511","span":{"begin":204,"end":208},"obj":"http://purl.obolibrary.org/obo/CLO_0051650"},{"id":"T512","span":{"begin":204,"end":208},"obj":"http://purl.obolibrary.org/obo/CLO_0052052"},{"id":"T513","span":{"begin":216,"end":221},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Inhibition of pseudovirus entry by SARS-CoV-2 RBD protein was carried out, as previously described, with some modifications.31 Briefly, SARS-CoV-2 RBD protein at serial dilutions was incubated with hACE2/293T target cells for 1 h at 37 °C."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T168","span":{"begin":50,"end":57},"obj":"Chemical"},{"id":"T169","span":{"begin":151,"end":158},"obj":"Chemical"}],"attributes":[{"id":"A168","pred":"chebi_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A169","pred":"chebi_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Inhibition of pseudovirus entry by SARS-CoV-2 RBD protein was carried out, as previously described, with some modifications.31 Briefly, SARS-CoV-2 RBD protein at serial dilutions was incubated with hACE2/293T target cells for 1 h at 37 °C."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T175","span":{"begin":0,"end":239},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Inhibition of pseudovirus entry by SARS-CoV-2 RBD protein was carried out, as previously described, with some modifications.31 Briefly, SARS-CoV-2 RBD protein at serial dilutions was incubated with hACE2/293T target cells for 1 h at 37 °C."}

    2_test

    {"project":"2_test","denotations":[{"id":"32203189-27750111-19774551","span":{"begin":124,"end":126},"obj":"27750111"}],"text":"Inhibition of pseudovirus entry by SARS-CoV-2 RBD protein was carried out, as previously described, with some modifications.31 Briefly, SARS-CoV-2 RBD protein at serial dilutions was incubated with hACE2/293T target cells for 1 h at 37 °C."}